Argent Advisors, Inc. Abb Vie Inc. Transaction History

Argent Advisors, Inc.

$267 Million
Q3 2024

A detailed history of Argent Advisors, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Argent Advisors, Inc. holds 2,331 shares of ABBV stock, worth $419,580. This represents 0.17% of its overall portfolio holdings.

Number of Shares

2,331

Previous 2,480 6.01%

Holding current value

$419,580

Previous $425,000 8.24%

% of portfolio

0.17%

Previous 0.17%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $24,412 - $29,700	-149 Reduced 6.01%	2,331 $460,000
Q2 2024 Jul 29, 2024	SELL	$154.79 - $180.76 $53,247 - $62,181	-344 Reduced 12.18%	2,480 $425,000
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $140,002 - $159,519	-876 Reduced 23.68%	2,824 $514,000
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $19,676 - $22,160	-143 Reduced 3.72%	3,700 $573,000
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $25,248 - $29,228	-189 Reduced 4.69%	3,843 $572,000
Q2 2023 Aug 04, 2023	SELL	$132.51 - $164.9 $46,511 - $57,879	-351 Reduced 8.01%	4,032 $543,000
Q1 2023 Apr 21, 2023	BUY	$144.61 - $166.54 $19,522 - $22,482	135 Added 3.18%	4,383 $698,000
Q4 2022 Feb 01, 2023	BUY	$138.31 - $165.87 $8,990 - $10,781	65 Added 1.55%	4,248 $686,000
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $25,365 - $29,092	189 Added 4.73%	4,183 $561,000
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $62,341 - $79,256	-453 Reduced 10.19%	3,994 $612,000
Q1 2022 Apr 26, 2022	BUY	$131.98 - $163.75 $49,360 - $61,242	374 Added 9.18%	4,447 $721,000
Q4 2021 Feb 02, 2022	BUY	$107.43 - $135.93 $216,686 - $274,170	2,017 Added 98.1%	4,073 $551,000
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $2,660 - $3,019	25 Added 1.23%	2,056 $222,000
Q2 2021 Aug 02, 2021	BUY	$105.21 - $117.21 $3,682 - $4,102	35 Added 1.75%	2,031 $229,000
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $265,059 - $291,798	-2,591 Reduced 56.49%	1,996 $216,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $28,171 - $38,034	350 Added 8.26%	4,587 $491,000
Q2 2020 Aug 11, 2020	BUY	$73.37 - $98.18 $104,625 - $140,004	1,426 Added 50.73%	4,237 $415,000
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $202,757 - $253,692	2,811 New	2,811 $248,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Argent Advisors, Inc. with notifications on news.

Account

Argent Advisors, Inc. Abb Vie Inc. Transaction History